科学研究
20190125 Genome Editing with mRNA Encoding ZFN, TALEN, and Cas9
编辑:www.4001.com  发布时间:2019-01-25  来源:  阅读次数:
Mol Ther. 2019 Jan 25. pii: S1525-0016(19)30017-6. doi: 10.1016/j.ymthe.2019.01.014. [Epub ahead of print]

Genome Editing with mRNA Encoding ZFN, TALEN, and Cas9.

Zhang HX 1, Zhang Y 2, Yin H 3.

Abstract

Genome-editing technologies based on programmable nucleases have significantly broadened our ability to make precise and direct changes in the genomic DNA of various species, including human cells. Delivery of programmable nucleases into the target tissue or cell is one of the pressing challenges in transforming the technology into medicine. In vitro-transcribed (IVT) mRNA-mediated delivery of nucleases has several advantages, such as transient expression with efficient in vivo and in vitro delivery, no genomic integration, a potentially low off-target rate, and high editing efficiency. This review focuses on key barriers related to IVT mRNA delivery, on developed modes of delivery, and on the application and future prospects of mRNA encoding nuclease-mediated genome editing in research and clinical trials.

 

地 址:湖北省武汉市武昌区东湖路115号 邮政编码:430071 电 话:027-68750205  邮 箱:mri@whu.edu.cn

CopyRight© 2016  版权所踊岷澳门百老汇4001登录网站

XML 地图 | Sitemap 地图